# FDA 483 - John D. Gabriel, MD - October 22, 2013

Source: https://www.keypedia.com/records/483/john-d-gabriel-md/3e27073f-6754-4838-a7da-96d5cf7927d8

> FDA 483 for John D. Gabriel, MD on October 22, 2013. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: John D. Gabriel, MD
- Inspection Date: 2013-10-22
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: John Gabriel, MD, a clinical research facility in North Richland Hills, TX, was issued a Form 483 with three observations following an FDA inspection. The inspection revealed significant deficiencies in the conduct of clinical investigations, including failures to adhere to investigational plans and protect subject welfare. Issues also encompassed inadequate investigational drug disposition records and inaccuracies in case histories.

## Related Officers

- [investigator](https://www.keypedia.com/people/terri-l-thomas/64ff3727-20db-4c43-a1b5-7cd653f95f32)

Company: https://www.keypedia.com/companies/john-d-gabriel-md/6c8dab33-f0fe-48ec-8b27-7c62dededa1f

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9